![]() Financial Daily from THE HINDU group of publications Tuesday, Aug 02, 2005 |
|
|
|
|
|
|
|
Corporate Results
-
Bio-tech & Genetics Sterling Biotech Q2 net up 53 pc Our Bureau
Mumbai , Aug. 1 STERLING Biotech has posted a 53.6 per cent rise in the net profit of the second quarter ended June at Rs 26.64 crore (Rs 17.34 crore). Total sales rose by 22.7 per cent to Rs 120 crore (Rs 97.8 crore), a note from the company said. For the half-year ended June 2005, the company's total sales stood at Rs 230.23 crore and net profit of Rs 51.19 crore. Mr Nitin Sandesara, Chairman, Sterling Biotech said: "The current quarter results reflect the benefits of cost and operational efficiencies. Sterling has more than seven per cent market share in pharma-gelatin globally and is well known for its product quality in developed countries. The expansion facility will further our position in the international market besides assuring a regular supply to our customers."
Article E-Mail :: Comment :: Syndication :: Printer Friendly Page
|
Stories in this Section |
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |
Copyright © 2005, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|